BOA Young Investigator Award
BOA1 – BOA25
- BOA1: A systematic review and meta-analysis of occupational exposure to benzene: leukemia in relation to benzene exposure
- BOA2: UK health professionals' attitudes and knowledge regarding human papilloma virus (HPV) vaccination
- BOA3: A phase I/II trial of radioimmunotherapy with 131Iodine labelled A5B7 anti-CEA antibody (131I-A5B7) in combination with Combretastatin-A4-Phosphate (CA4P) in advanced gastrointestinal carcinomas
- BOA4: Does breast reconstruction improve quality of life for women facing mastectomy? A systematic review
- BOA5: Does the cosmetic outcome of breast reconstruction influence patient satisfaction or quality of life? A comparison of patients and healthcare professionals perspectives
- BOA6: Identification of men with a genetic predisposition to prostate cancer: targeted screening of BRCA1 and BRCA2 mutation carriers and controls. The IMPACT study - pilot results
- BOA7: The use of Nutlin-3 as a radiosensitiser in laryngeal carcinoma cells harbouring wild-type p53
- BOA8: Systematic analysis of genetic alterations in prostate cancer
- BOA9: Pegylated liposomal doxorubicin for epithelial ovarian cancer: the utility of Ca125 trends in guiding treatment decisions and subsequent response to platinum retreatment
- BOA10: A population-based study of marriage and divorce in survivors of adult cancers in Norway
- BOA11: The effects of Metastasis Tumour Supressor-1 (MTSS1) gene on non small cell lung cancer
- BOA12: The potential utility of circulating tumour cells (CTCs) as biomarkers in small cell lung cancer (SCLC)
- BOA13: Effect of diet on APC mutation spectra in sporadic colorectal tumours from the EPIC-Norfolk Study
- BOA14: Febrile neutropaenia in patients receiving TAC chemotherapy for breast cancer
- BOA15: Lifestyle factors and p53 mutations in sporadic colorectal cancer in the EPIC-Norfolk study
- BOA16: ‘My friends love to tan’: examining sensation seeking and mediating role of association with friends who use tanning beds
- BOA17: The APC variant E1317Q predisposes to colorectal adenomas by relaxing the target for tumourigenic somatic APC mutations
- BOA18: Protective effect of fibre on colorectal cancer: results from EPIC-Norfolk
- BOA19: Evaluation of elevated choline metabolism in patients with endocrine resistant breast cancer using [11C]choline and [18F]fluorothymidine PET
- BOA20: A Phase II study of PTK787 in patients with metastatic melanoma (CAMEL02)
- BOA21: Molecular genetic and epigenetic analysis of paediatric low-grade gliomas
- BOA22: A Phase I study of AZD2281 (KU-0059436), a PARP (poly ADP-ribose polymerase) inhibitor: results in patients with BRCA deficient ovarian cancer (BDOC)
- BOA23: What factors facilitate or impede family communication following genetic testing for cancer risk? A systematic review and meta-synthesis
- BOA24: Targeting inflammatory cytokines using adenoviruses- gene delivery of biological therapies in ovarian cancer
- BOA25: Using the Drosophila protein to further our understanding of BRCA2
